Mon, 10 Aug 2026
Pharma in Focus

Connecting you with your industry every day

Login

Last Seven Days

27 articles from the last seven days

  • New rival ready to crash CAR-T market

    A new CAR-T submitted to the TGA and MSAC looks set to take on Novartis' Kymriah and Gilead's Yescarta

    6 Aug 2026
  • Brown nosing allowed, court rules

    The Full Federal Court has come down in favour of the National Cancer Foundation's 'somewhat confronting' Brown Nose campaign

    3 Aug 2026
  • Med affairs, the time is now

    A call to action has sounded: This cross-disciplinary team is urging a fundamental change to how Medical Affairs reach HCPs

    4 Aug 2026
  • Pharma exec up for Patient Choice gong

    77 finalists across 15 categories selected by the patients, families, colleagues and communities who have experienced their work first-hand

    31 Jul 2026
  • Doctors turn up the heat on pharma

    Pharma is not alone in feeling frustration over timely access to medicines, doctors are feeling the pain too and want industry to fix it

    10 Aug 2026
  • More to the story for patients

    Pharma innovation has greatly extended the lifespan of people living with this disease, but now there are new challenges

    7 Aug 2026
  • After 8 OS deaths TGA reviews drug

    With overseas regulators well down the path to removing this treatment from their market, the TGA has announced it's undertaking a review

    4 Aug 2026
Pharma in Focus

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 
Not a member? Sign up here
Pharma in Focus